Abiopharma

News list

Booth Andrew 🟢 acquired 37.2K shares of AbCellera Biologics Inc. (ABCL) at $10.32 Transaction Date: Aug 14, 2026 | Filing ID: 000008

Full text

News bot Aug. 14, 2026, 5:10 p.m.
🔍 Booth Andrew (Executive)

Company: AbCellera Biologics Inc. (ABCL)

Report Date: 2026-08-14
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 0
- Holdings reported: 1
- Total shares acquired: 37,200
- Total shares held: 130,959
Detailed Transactions and Holdings:
- Acquired 37,200 shares of Common Shares at $10.32 per share (Direct)
  Date: 2026-08-14 | Code: P | equity_swap_involved: 0 | shares_owned_after: 482,800.00 | transaction_form_type: 5
- Holds 0 shares of Common Shares (Direct)
  Date: 2026-08-14 | Code: H | nature_of_ownership: By spouse | shares_owned_after: 130,959.00